BROADCASTS.com

b'Throughout the show\\u2019s history, we\\u2019ve done interviews with medical professionals and those pursuing innovations in the medical field. This week\\u2019s guest created a breakthrough product used during this global pandemic. Clive Smith, the CEO and founder of Thinklabs joins us on the show. We will discuss a medical innovation and what he\\u2019s doing to disrupt the field.
\\n
\\nClive\\u2019s Background
\\nClive grew up in South Africa. Greatly influenced by the moon landing as a kid, which showed that technology happens in the United States, he knew where he needed to be. Clive studied for his masters at the California Institute of Technology and focused on analog electronics and signal processing. After finishing school, he worked in the corporate world for a few years but realized that was not what he wanted to do. While he didn\\u2019t stay there, he is grateful for what he was able to learn.
\\nAfter leaving corporate America, Clive started Thinklabs. The context was that it would be an incubator for Clive\\u2019s and other people\\u2019s ideas. He had a long-term interest in medical devices, and while at his undergrad in South Africa, he developed an electrocardiographic device with a friend. On top of that, many of Clive\\u2019s friends from school went on to become doctors. Clive\\u2019s brother was also a cardiologist, so being surrounded by the medical professionals boosted Clive\\u2019s interest.
\\nStethoscope Medical Innovation
\\nClive stumbled across an article in a cardiology journal about the stethoscope. The journal people measured the acoustics on stethoscopes and studied the original stethoscope made by Rene Laennec. They realized that the acoustics of the original was almost the same as the modern stethoscope. The device hadn\\u2019t had a performance improvement for nearly 180 years.
\\nClive decided that he was going to fix the issue and started prototyping in his garage. He came up with a unique sensor for the stethoscope. After talking with cardiologists and comparing his medical innovations to others, Clive started talking with HP medical. They ended up funding his product, but while they were funding it, another company bought the healthcare division.
\\nDue to Clive\\u2019s contract, he could leave and put all the technology out on the market himself. The first version of the stethoscope came to the market in 2003 and manufactured in China. In 2013, the production of the product moved from China to the U.S.
\\nManufacturing and Product Use
\\nClive made himself more vertically integrated when he moved from offshore manufacturing to onshore. He did this because he wanted to be able to innovate quickly. Outside manufacturers like the ones in China want to crank out a product efficiently and keep things moving. It\\u2019s not that easy to make changes with all of that. Another part of it was 3D printing. 3D printing offers flexibility because it is mostly software.
\\nMoving onshore wasn\\u2019t mainly for the cost nor \\u201cfor American manufacturing\\u201d. Many of the suppliers in the U.S had a hard time making high-quality products that Clive wanted. He ended up with a global supply chain as he does assembly in the U.S but gets some components from Japan, China, etc.
\\nWith regards to Clive\\u2019s digital stethoscope, some physicians are particularly interested in listening to sounds. Many people still use conventional stethoscopes, and if they hear something that sounds weird, they pass it on to a specialist. Users of the digital stethoscope use it to get a more thorough read upfront. On top of that, regular stethoscopes are known to carry diseases and pathogens and not useful in infectious situations.
\\nCalled on to help doctors in 2014,'